| scholarly article | Q13442814 |
| P50 | author | Adam Lane | Q50740734 |
| Matthew N Alder | Q57324371 | ||
| P2093 | author name string | Pooja Khandelwal | |
| Sonata Jodele | |||
| Stella M Davies | |||
| Bridget Litts | |||
| Nicholas J Gloude | |||
| Alyss Wilkey | |||
| Dana T Lounder | |||
| Kelly E Lake | |||
| Nathan Luebbering | |||
| P2860 | cites work | Neutrophil Extracellular Traps in Pulmonary Diseases: Too Much of a Good Thing? | Q26738321 |
| A new paradigm: Diagnosis and management of HSCT-associated thrombotic microangiopathy as multi-system endothelial injury | Q26992169 | ||
| Neutrophil extracellular traps kill bacteria | Q27860996 | ||
| "The NET Outcome": Are Neutrophil Extracellular Traps of Any Relevance to the Pathophysiology of Autoimmune Disorders in Childhood? | Q28070285 | ||
| Netting neutrophils in autoimmune small-vessel vasculitis | Q29615432 | ||
| Small vessels, big trouble in the kidneys and beyond: hematopoietic stem cell transplantation-associated thrombotic microangiopathy | Q33395413 | ||
| Circulating DNA and myeloperoxidase indicate disease activity in patients with thrombotic microangiopathies | Q33401314 | ||
| Abnormalities in the alternative pathway of complement in children with hematopoietic stem cell transplant-associated thrombotic microangiopathy | Q33408788 | ||
| Serum neutrophil extracellular trap levels predict thrombotic microangiopathy after allogeneic stem cell transplantation | Q33410486 | ||
| Eculizumab therapy in children with severe hematopoietic stem cell transplantation-associated thrombotic microangiopathy. | Q33412325 | ||
| Diagnostic and risk criteria for HSCT-associated thrombotic microangiopathy: a study in children and young adults | Q33415603 | ||
| Variable Eculizumab Clearance Requires Pharmacodynamic Monitoring to Optimize Therapy for Thrombotic Microangiopathy after Hematopoietic Stem Cell Transplantation. | Q33426602 | ||
| New approaches in the diagnosis, pathophysiology, and treatment of pediatric hematopoietic stem cell transplantation-associated thrombotic microangiopathy | Q33432069 | ||
| Thrombosis: tangled up in NETs | Q33556910 | ||
| Heme-induced neutrophil extracellular traps contribute to the pathogenesis of sickle cell disease | Q33749670 | ||
| Enhanced neutrophil extracellular trap generation in rheumatoid arthritis: analysis of underlying signal transduction pathways and potential diagnostic utility. | Q34500576 | ||
| Netting neutrophils induce endothelial damage, infiltrate tissues, and expose immunostimulatory molecules in systemic lupus erythematosus. | Q35059002 | ||
| Platelets induce neutrophil extracellular traps in transfusion-related acute lung injury | Q36068299 | ||
| Neutrophils activate plasmacytoid dendritic cells by releasing self-DNA-peptide complexes in systemic lupus erythematosus | Q36102468 | ||
| Neutrophil extracellular trap (NET) impact on deep vein thrombosis | Q36391500 | ||
| Neutrophil extracellular traps: A new link to cancer-associated thrombosis and potential implications for tumor progression | Q36694910 | ||
| Deficient Neutrophil Extracellular Trap Formation in Patients Undergoing Bone Marrow Transplantation | Q37039075 | ||
| NETs are a source of citrullinated autoantigens and stimulate inflammatory responses in rheumatoid arthritis | Q37056181 | ||
| None of the above: thrombotic microangiopathy beyond TTP and HUS. | Q39247002 | ||
| NETosing Neutrophils Activate Complement Both on Their Own NETs and Bacteria via Alternative and Non-alternative Pathways | Q40171437 | ||
| Chemokines and tissue injury | Q40543142 | ||
| The first subcomponent of complement, C1q, triggers the production of IL-8, IL-6, and monocyte chemoattractant peptide-1 by human umbilical vein endothelial cells | Q42465660 | ||
| Intravascular neutrophil extracellular traps capture bacteria from the bloodstream during sepsis | Q42512724 | ||
| ST2 and Endothelial Injury as a Link between GVHD and Microangiopathy | Q87633830 | ||
| P433 | issue | 10 | |
| P407 | language of work or name | English | Q1860 |
| P1104 | number of pages | 8 | |
| P304 | page(s) | 1259-1266 | |
| P577 | publication date | 2017-07-13 | |
| P1433 | published in | Blood | Q885070 |
| P1476 | title | Circulating dsDNA, endothelial injury, and complement activation in thrombotic microangiopathy and GVHD | |
| P478 | volume | 130 |
| Q91838682 | A critical role of the Gas6-Mer axis in endothelial dysfunction contributing to TA-TMA associated with GVHD |
| Q58553367 | Clinical and morphological practices in the diagnosis of transplant-associated microangiopathy: a study on behalf of Transplant Complications Working Party of the EBMT |
| Q57456627 | Complement-mediated thrombotic microangiopathy as a link between endothelial damage and steroid-refractory GVHD |
| Q92860794 | Extracellular DNA traps in inflammation, injury and healing |
| Q62029355 | High mortality in hematopoietic stem cell transplant-associated thrombotic microangiopathy with and without concomitant acute graft-versus-host disease |
| Q90623554 | Interferon-complement loop in transplant-associated thrombotic microangiopathy |
| Q48109327 | Recent advances in pathophysiology of disseminated intravascular coagulation: the role of circulating histones and neutrophil extracellular traps |
| Q64093787 | Systemic inflammation induces release of cell-free DNA from hematopoietic and parenchymal cells in mice and humans |
| Q91937157 | The emerging role of immunothrombosis in paediatric conditions |
| Q64063450 | Transplant-Associated Thrombotic Microangiopathy in Pediatric Hematopoietic Cell Transplant Recipients: A Practical Approach to Diagnosis and Management |
| Q58561025 | Transplant-associated thrombotic microangiopathy: is the treatment more expensive than the disease? |
| Q102141644 | Uncovering the multifaceted roles played by neutrophils in allogeneic hematopoietic stem cell transplantation |
| Q90590296 | Vascular endothelial syndromes after HCT: 2020 update |
Search more.